Healthcare

The proceeds from the new issuance will be used alongside a concurrent buyback of approximately A$637 million of Telix's existing 2029 convertible notes. The company said more than 85 per cent of those notes are expected to be repurchased and cancelled, with Telix indicating …

Chief executive Silviu Itescu told the market the acquisition supports a strategy to expand the indications Mesoblast's cell therapies can address and lift their efficacy against more complex inflammatory and autoimmune conditions. Initial therapeutic applications, the company said, are expected in ulcerative colitis, Crohn's …

Avita Medical Inc. (ASX:AVH) delivered a notable intraday gain on 15 April 2026, with shares advancing $0.169 or approximately 12.7% to $1.510 during the session. Trading volume of 1,080,434 shares reflected a material increase in investor activity, with the bid and offer range of …

Genetic Signatures Limited (ASX:GSS) delivered the session's strongest percentage gain among the companies covered in this analysis, with shares advancing $0.018 or 22.2% to $0.099 during the 15 April 2026 trading session. Volume of 638,674 shares was high relative to the company's typical trading …

Xenitra Limited (ASX:XEN) traded at $0.003 during the session on 15 April 2026, unchanged on the day despite the release of a price-sensitive acquisition announcement. Volume of 1,323,824 shares was notably high for a stock trading at sub-cent levels, suggesting that the announcement generated …

Entropy Neurodynamics Ltd (ASX:ENP) continues to advance its clinical-stage program for Binge Eating Disorder (BED), yet its share price remained unchanged at A$0.030 on 14 April 2026. The company’s latest update, confirming successful dosing of a third patient in its TRP-8803 trial, underscores steady …

Telix Pharmaceuticals Ltd (ASX:TLX) has emerged as a prominent player in the rapidly evolving radiopharmaceutical sector, delivering strong financial and operational performance through 2025. However, despite reporting significant revenue growth and achieving underlying profitability, the company’s share price fell 2.03% to A$15.45 on 14 …